Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone as an Adjuvant to Ropivacaine for Adductor Canal Block in Total Knee Arthroplasty
NCT07722234Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of hydromorphone in postoperative pain (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Visual Analog Scale at 24 hours. Started Mar 2026; status: completed.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07722234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07722234.